1. Search Result
Search Result
Results for "

Myelin oligodendrocyte glycoprotein

" in MedChemExpress (MCE) Product Catalog:

9

Inhibitors & Agonists

8

Peptides

1

Inhibitory Antibodies

9

Recombinant Proteins

Cat. No. 상품명 Target 연구분야 Chemical Structure
  • HY-P1240
    MOG (35-55) mouse, rat
    Maximum Cited Publications
    9 Publications Verification

    Myelin oligodendrocyte glycoprotein Peptide (35-55), mouse, rat

    Endogenous Metabolite Neurological Disease Inflammation/Immunology
    MOG (35-55) mouse, rat (Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat) is a minor component of CNS myelin. MOG (35-55) mouse, rat has encephalitogenic activity and induces T cell proliferative. MOG (35-55) mouse, rat induces Th1 cytokine response as well as relatively high levels of IgG antibodies. MOG (35-55) mouse, rat produces a relapsing-remitting neurological disease with extensive plaque-like demyelination. MOG (35-55) mouse, rat (MOG (35-55)) can be used for experimental autoimmune encephalomyelitis (EAE) modeling .
    MOG (35-55)  mouse, rat
  • HY-P3719
    MOG(35-55) amide, mouse, rat
    1 Publications Verification

    CCR Inflammation/Immunology
    MOG (35-55) amide, mouse, rat the terminal amidation form of the 35-55 fragment of the myelin oligodendrocyte glycoprotein (MOG) immunogenic peptide (MOG (35-55) (HY-P1240)). MOG(35-55) amide, mouse, rat can be used for experimental autoimmune encephalomyelitis (EAE) modeling .
    MOG(35-55) amide, mouse, rat
  • HY-P1240A
    MOG (35-55) TFA
    Maximum Cited Publications
    9 Publications Verification

    Myelin oligodendrocyte glycoprotein Peptide (35-55), mouse, rat TFA

    Endogenous Metabolite Neurological Disease Inflammation/Immunology
    MOG (35-55) (MOG (35-55)) TFA is a minor component of CNS myelin. MOG (35-55) (TFA) has encephalitogenic activity and induces T cell proliferative. MOG (35-55) (TFA) induces Th1 cytokine response as well as relatively high levels of IgG antibodies. MOG (35-55) (TFA) produces a relapsing-remitting neurological disease with extensive plaque-like demyelination. MOG (35-55) (MOG (35-55)) TFA can be used for experimental autoimmune encephalomyelitis (EAE) modeling .
    MOG (35-55) TFA
  • HY-P5966

    MOG (40-54)

    MHC Inflammation/Immunology
    Myelin Oligodendrocyte Glycoprotein (40-54), Rat, Mouse (MOG (40-54)) is a CD8-related self-antigenic epitope of the myelin oligodendrocyte glycoprotein (MOG) protein and is presented in association with H-2Db .
    Myelin Oligodendrocyte Glycoprotein (40-54), Rat, Mouse
  • HY-P990138

    CD20 Metabolic Disease Inflammation/Immunology
    Anti-Monkey/Human CD20 Antibody (2H7) is a mouse-derived IgG2b κ type antibody inhibitor, targeting to monkey/human CD20. Anti-Monkey/Human CD20 Antibody (2H7) specifically depletes B cells. Anti-Monkey/Human CD20 Antibody (2H7) can be used for the researches of inflammation and metabolic disease, such as diabetes and experimental autoimmune encephalomyelitis .
    Anti-Monkey/Human CD20 Antibody (2H7)
  • HY-P2461

    MHC Neurological Disease
    MOG (89-113), human is a peptide fragment of human myelin oligodendrocyte glycoprotein.
    MOG (89-113), human
  • HY-112219

    Histamine Receptor Inflammation/Immunology Endocrinology
    H3R antagonist 1 is a histamine receptor 3 (H3R) inverse agonist. H3R antagonist 1 increases the expression levels of myelin-associated glycoprotein (MAG) and myeline basic protein (MBP) in differentiating oligodendrocytes. H3R antagonist 1 can be used for the study of multiple sclerosis .
    H3R antagonist 1
  • HY-112219A

    Histamine Receptor Inflammation/Immunology Endocrinology
    H3R antagonist 1 hydrochloride is a histamine receptor 3 (H3R) inverse agonist. H3R antagonist 1 hydrochloride increases the expression levels of myelin-associated glycoprotein (MAG) and myeline basic protein (MBP) in differentiating oligodendrocytes. H3R antagonist 1 hydrochloride can be used for the study of multiple sclerosis .
    H3R antagonist 1 hydrochloride
  • HY-158688

    PI3K Inflammation/Immunology
    PI3Kδ-IN-21 (Compound 31) is a selective inhibitor for phosphoinositide 3-kinases δ (PI3Kδ), with an IC50 of 13.6 nM. PI3Kδ-IN-21 inhibits proliferation and differentation of T cells through PI3K/AKT/mTOR signaling pathway. PI3Kδ-IN-21 exhibits good pharmacokinetic characters in rat model, and attenuates the experimental autoimmune encephalomyelitis in myelin oligodendrocyte glycoprotein (MOG)-induced EAE model .
    PI3Kδ-IN-21

온라인 문의

Your information is safe with us. * Required Fields.

호칭

 

Country or Region *

고객명 *

 

회사명 *

Department *

     

메일주소 *

 

상품명 *

Cat. No.

 

Requested quantity *

전화번호 *

     

비고

온라인 문의

Inquiry Information

상품명:
Cat. No.:
수량:
MCE Japan Authorized Agent: